Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nephrin protein is a large transmembrane cell adhesion molecule expressed predominantly on the surface of podocytes in the glomeruli of the kidney. It forms a crucial part of the slit diaphragm, a specialized junction that functions as both a physical and signaling barrier, preventing leakage of plasma proteins into urine and maintaining kidney filtration selectivity. Nephrin consists of multiple extracellular immunoglobulin-like domains and a cytoplasmic tail with conserved tyrosine residues that interact with scaffolding and signaling proteins, such as MAGI1 and Nck, to regulate podocyte structure and signaling. Mutations in the NPHS1 gene encoding nephrin disrupt its structural integrity or signaling function, resulting in congenital nephrotic syndrome (especially the Finnish type) and other severe proteinuric kidney diseases. Research continues into how nephrin's assembly at the slit diaphragm underpins renal health and how experimental agents may modify nephrin-related signaling in disease models.
Not applicable for approved drugs; experimental mechanism includes blocking nephrin/MAGI1 signaling complex in the slit diaphragm
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nephrin protein (Nephrin).